No abstract available
MeSH terms
-
Animals
-
Cardiovascular Agents*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / physiopathology
-
Glycosylation
-
Hemodynamics / drug effects*
-
Humans
-
Hypoglycemic Agents / pharmacology*
-
Hypoglycemic Agents / therapeutic use*
-
Metformin / pharmacology*
-
Metformin / therapeutic use*
-
Neovascularization, Pathologic / prevention & control
-
Neovascularization, Physiologic / drug effects
-
Oxidation-Reduction
Substances
-
Cardiovascular Agents
-
Hypoglycemic Agents
-
Metformin